These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23370589)

  • 1. Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen.
    Pratini NR; Sweeters N; Vichinsky E; Neufeld JA
    Am J Phys Med Rehabil; 2013 Aug; 92(8):728-33. PubMed ID: 23370589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.
    Cossu G; Abbruzzese G; Matta G; Murgia D; Melis M; Ricchi V; Galanello R; Barella S; Origa R; Balocco M; Pelosin E; Marchese R; Ruffinengo U; Forni GL
    Parkinsonism Relat Disord; 2014 Jun; 20(6):651-4. PubMed ID: 24661465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.
    Klopstock T; Tricta F; Neumayr L; Karin I; Zorzi G; Fradette C; Kmieć T; Büchner B; Steele HE; Horvath R; Chinnery PF; Basu A; Küpper C; Neuhofer C; Kálmán B; Dušek P; Yapici Z; Wilson I; Zhao F; Zibordi F; Nardocci N; Aguilar C; Hayflick SJ; Spino M; Blamire AM; Hogarth P; Vichinsky E
    Lancet Neurol; 2019 Jul; 18(7):631-642. PubMed ID: 31202468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantothenate - kinase associated neurodegeneration.
    Parmar A; Khare S; Srivastav V
    J Assoc Physicians India; 2012 Apr; 60():74-6. PubMed ID: 23029753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients.
    Rohani M; Razmeh S; Shahidi GA; Alizadeh E; Orooji M
    Neurol Int; 2017 Dec; 9(4):7279. PubMed ID: 29619158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy.
    Kyriagis M; Grattan-Smith P; Scheinberg A; Teo C; Nakaji N; Waugh M
    J Paediatr Child Health; 2004; 40(5-6):322-5. PubMed ID: 15151592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial.
    Zorzi G; Zibordi F; Chiapparini L; Bertini E; Russo L; Piga A; Longo F; Garavaglia B; Aquino D; Savoiardo M; Solari A; Nardocci N
    Mov Disord; 2011 Aug; 26(9):1756-9. PubMed ID: 21557313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
    Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
    J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.
    Iankova V; Karin I; Klopstock T; Schneider SA
    Front Neurol; 2021; 12():629414. PubMed ID: 33935938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia.
    Albright AL; Barry MJ; Fasick P; Barron W; Shultz B
    Neurosurgery; 1996 May; 38(5):934-8; discussion 938-9. PubMed ID: 8727818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design of Novel Therapies for Pantothenate Kinase-Associated Neurodegeneration.
    Thakur N; Klopstock T; Jackowski S; Kuscer E; Tricta F; Videnovic A; Jinnah HA
    Mov Disord; 2021 Sep; 36(9):2005-2016. PubMed ID: 34002881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation.
    Abbruzzese G; Cossu G; Balocco M; Marchese R; Murgia D; Melis M; Galanello R; Barella S; Matta G; Ruffinengo U; Bonuccelli U; Forni GL
    Haematologica; 2011 Nov; 96(11):1708-11. PubMed ID: 21791473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal dystrophies.
    Nardocci N; Zorzi G
    Handb Clin Neurol; 2013; 113():1919-24. PubMed ID: 23622415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration.
    Santambrogio P; Ripamonti M; Paolizzi C; Panteghini C; Carecchio M; Chiapparini L; Raimondi M; Rubio A; Di Meo I; Cozzi A; Taverna S; De Palma G; Tiranti V; Levi S
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).
    Hogarth P; Kurian MA; Gregory A; Csányi B; Zagustin T; Kmiec T; Wood P; Klucken A; Scalise N; Sofia F; Klopstock T; Zorzi G; Nardocci N; Hayflick SJ
    Mol Genet Metab; 2017 Mar; 120(3):278-287. PubMed ID: 28034613
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Status dystonicus and Hallervorden-Spatz disease.
    Flett PJ
    J Paediatr Child Health; 2004 Dec; 40(12):721. PubMed ID: 15569297
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychological functions and psychiatric symptoms in late-onset manifestation of pantothenate kinase-associated neurodegeneration: a clinical case report.
    Palmeri R; Lo Buono V; Berenati M; Caporale M; Stroscio G; Di Lorenzo G; Bramanti A; Sorbera C; Marino S
    Int J Neurosci; 2020 May; 130(5):490-492. PubMed ID: 31738088
    [No Abstract]   [Full Text] [Related]  

  • 18. Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation.
    Álvarez-Córdoba M; Fernández Khoury A; Villanueva-Paz M; Gómez-Navarro C; Villalón-García I; Suárez-Rivero JM; Povea-Cabello S; de la Mata M; Cotán D; Talaverón-Rey M; Pérez-Pulido AJ; Salas JJ; Pérez-Villegas EM; Díaz-Quintana A; Armengol JA; Sánchez-Alcázar JA
    Mol Neurobiol; 2019 May; 56(5):3638-3656. PubMed ID: 30173408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration with brain iron accumulation.
    Gregory A; Hayflick SJ
    Folia Neuropathol; 2005; 43(4):286-96. PubMed ID: 16416393
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.